Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status.
暂无分享,去创建一个
I. Tannock | G. Pond | B. O'Sullivan | John J. Kim | L. Siu | J. Ringash | B. Cummings | A. Bayley | E. Chen | M. Bahl | J. Waldron | B. Lemon | L. Gitterman